SCHEMBL4943317

SCHEMBL4943317

CC(=O)N(CCc1ccc(C(=O)O)cc1)NCCC(O)Cc1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
POLB P06746 4/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
PTGER4 P35408 3/20 0.38
PTGER2 P43116 3/20 0.38
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
PPARG P37231 2/20 0.37
PPARA Q07869 1/20 0.37
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
ADRB1 P08588 3/20 0.36
ADRB3 P13945 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5988841 0.91 ALDH1A1 (0.41) ALDH1A1POLBMEN1KMT2ATMEM97
SCHEMBL13992258 0.91 TMEM97 (0.42) ALDH1A1MEN1KMT2ATMEM97SIGMAR1
SCHEMBL4939912 0.91 PTGER4 (0.45) POLBMEN1KMT2APTGER4PTGER2
SCHEMBL4943283 0.89 PTGER4 (0.40) ALDH1A1PTGER4PTGER2NR4A2SMN1; SMN2
SCHEMBL4941608 0.89 PTGER4 (0.51) PTGER4PTGER2ADRB1ADRB3
SCHEMBL13992409 0.88 ADRB1 (0.44) ALDH1A1MEN1KMT2APTGER4PTGER2
SCHEMBL4942011 0.85 ACACB (0.47) PTGER4PTGER2
SCHEMBL13992254 0.84 TRPA1 (0.43) ALDH1A1MEN1KMT2ASIGMAR1ALOX15
SCHEMBL4945967 0.83 KMT2A (0.39) ALDH1A1MEN1KMT2APTGER4PTGER2
SCHEMBL4942974 0.83 BCL2 (0.43) PTGER4PTGER2ADRB1ADRB3EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465755-B2 Hydrazide derivatives as prostaglandin receptors modulators LABORATOIRES SERONO SA (CH) 2008-12-16 US claimed
US-20070185191-A1 Hydrazide derivatives as prostaglandin receptors modulators APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-09 US claimed
EP-1654219-A2 HYDRAZIDE DERIVATIVES AS PROSTAGLANDIN RECEPTORS MODULATORS Applied Research Systems ARS Holding N.V. (AN) 2006-05-10 EP claimed
WO-2005012232-A2 HYDRAZIDE DERIVATIVES AS PROSTAGLANDIN RECEPTORS MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2005-02-10 WO claimed
US-7465755-B2 Hydrazide derivatives as prostaglandin receptors modulators LABORATOIRES SERONO SA (CH) 2008-12-16 US disclosed
US-7465755-B2 Hydrazide derivatives as prostaglandin receptors modulators LABORATOIRES SERONO SA (CH) 2008-12-16 US disclosed
US-20070185191-A1 Hydrazide derivatives as prostaglandin receptors modulators APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-09 US disclosed
US-20070185191-A1 Hydrazide derivatives as prostaglandin receptors modulators APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-09 US disclosed
US-20070185191-A1 Hydrazide derivatives as prostaglandin receptors modulators APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185191-A1 Hydrazide derivatives as prostaglandin receptors modulators PTGIR, HPGDS, PGF ALDH1A1 163/4885POLB 3118/4885MEN1 4652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.